Henry Schein, Inc. (NASDAQ:HSIC) is Leith Wheeler Investment Counsel Ltd.'s 7th Largest Position

Key Points

• Leith Wheeler Investment Counsel Ltd. reduced its stake in Henry Schein, Inc. by 7.9%, bringing its total shares to 533,157, accounting for 2.5% of its overall portfolio.
• Henry Schein’s most recent quarterly earnings reported $1.10 EPS, missing the consensus estimate of $1.19, despite revenues of $3.24 billion slightly exceeding expectations.
• Analysts have generally downgraded their price targets for Henry Schein, with the current consensus rating being "Hold" and an average price target of $75.58.

Leith Wheeler Investment Counsel Ltd. cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 7.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 533,157 shares of the company's stock after selling 45,811 shares during the quarter. Henry Schein comprises 2.5% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its 7th biggest position. Leith Wheeler Investment Counsel Ltd. owned about 0.44% of Henry Schein worth $36,516,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Palestra Capital Management LLC acquired a new position in Henry Schein in the 4th quarter valued at about $182,988,000. Steadfast Capital Management LP boosted its holdings in Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Hudson Bay Capital Management LP boosted its holdings in Henry Schein by 102.1% in the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock valued at $101,378,000 after purchasing an additional 740,007 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Henry Schein in the 4th quarter valued at about $34,720,000. Finally, Ananym Capital Management LP purchased a new stake in shares of Henry Schein in the 4th quarter valued at approximately $32,628,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HSIC. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 price target (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Evercore ISI reduced their target price on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating on the stock in a report on Wednesday, August 6th. Finally, Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, Henry Schein has a consensus rating of "Hold" and a consensus price target of $75.58.

Henry Schein Stock Down 0.1%

NASDAQ HSIC traded down $0.07 on Friday, hitting $67.84. 1,675,382 shares of the stock were exchanged, compared to its average volume of 2,075,710. The company has a 50-day moving average price of $70.81 and a 200-day moving average price of $70.85. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.23 billion, a PE ratio of 21.88, a PEG ratio of 2.24 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company's quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.23 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.